ArticleInternational journal of clinical and experimental pathology2012
The histopathological spectrum of human meningiomas.
Article in International journal of clinical and experimental pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
89 citing papers in PubMed, 2 syntheses or guidelines pooled it, 168 citations in OpenAlex.
- Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis.Brain tumor pathology · 2022Pooled it
- Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review.Acta neurochirurgica · 2017Pooled it
- Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.Neuro-oncology · 2023Trial
- High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.International journal of radiation oncology, biology, physics · 2020Trial
- Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.Journal of neurosurgery · 2018Trial
- Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.Neuro-oncology · 2016Trial
- Immune-Enriched Versus Matrix-Remodeling Microenvironments in Psammoma Body-Rich and Psammoma Body-Poor WHO Grade I Meningiomas: An Exploratory Transcriptomic Study.Neuropathology : official journal of the Japanese Society of Neuropathology · 2026Article
- Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance.Nuclear medicine communications · 2026Review
- Human Meningiomas Reveal No Evidence of Neuroendocrine Differentiation.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026Article
- Novel predictors of tumor growth by exploratory quantitative analysis of radiomics features from MRI data for incidentally discovered meningioma.Journal of neuro-oncology · 2025Article
- Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells.Journal of neuro-oncology · 2025Article
- Extracranial Extension of a Convexity Meningioma into the Temporal Fossa: A Rare Case Report and Literature Review.Diagnostics (Basel, Switzerland) · 2025Article
- Expanding the therapeutic horizon ofNagoya journal of medical science · 2025Review
- Pathophysiological role and clinical applications of HER-2 expression in meningiomas: a systematic review.Annals of medicine and surgery (2012) · 2025Article
- Atypical presentation of a large posterior falx meningioma involving the parafalcine region in a 78-year-female: A case report.World journal of clinical cases · 2025Article
- Distinguishing Intracranial Solitary Fibrous Tumors from Meningiomas: The Diagnostic Value of T1-Weighted MRI Signal Intensity and ADC Values.AJNR. American journal of neuroradiology · 2025Article
- A Case Report Depicting a Rare Neurosurgical Disease: Aggressive Meningiomatosis.Journal of clinical medicine · 2025Article
- Tumour-associated macrophages in human meningiomas.PloS one · 2025Article
- Atypical meningiomas compared to other WHO Grade 2 meningiomas: Histological features and prognosis.Neurosciences (Riyadh, Saudi Arabia) · 2024Article
- Meningioma Prognostic Tool Based on Correlation of Histopathological Grading and Immunohistochemistry.Oman medical journal · 2024Article
29 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Histopathological examination and grading of meningiomas gives valuable prognostic information, although the method is subject for interobserver variability. The aim of this study was to review a large series of human meningiomas in order to examine the frequency of benign (grade I), atypical (grade II), and anaplastic (grade III) forms depending on various WHO classification schemes. In addition, we wanted to describe the frequency of various histopathological features and their mutual correlations. Sections from 196 consecutively treated primary human meningioma patients were revised retrospectively. The established criteria to grade meningiomas, which are also known to be associated with tumorigenesis, were shown to correlate significantly. The number of grade II meningiomas increased when using the WHO 2007 classification (30%) compared with previous editions, mainly due to the definition of brain infiltrating meningiomas as atypical (grade II). bimodal frequency distribution among age groups of females was observed. Continuous revision of histopathological classification systems is required to improve the diagnostic accuracy.
Indexed as
Identifiers
22558478PMC3341686W1536369388What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.